Skip to main content

Gracey Craig's Form 4/A amendment

Amended

Omada Health, Inc. (OMDA) · filed Jul 8, 2026

Accession no.
0001610717-26-000332
Filed
Jul 8, 2026, 8:19 PM ET
Trade date
Jun 22, 2026
Filing delay
16 days
Rule 10b5-1 plan
Checked
Original filed
Jun 24, 2026

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $37.5K. It was filed 16 days after the trade.

This amendment replaces 0001610717-26-000291 (filed Jun 24, 2026).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gracey CraigCIK 0002021724Officer (Chief Accounting Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 22, 2026Common StockMOption exerciseAcquired+2,083$6.57+$13,685.3117,524Direct
Jun 22, 2026Common StockSSaleDisposed−2,083$18.00−$37,49415,441Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 22, 2026Common StockMOption exerciseDisposed−2,083$0.00$041,667Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

F2

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

F3

25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read the full filing on SEC EDGAR (opens in a new tab)